Elanco Animal Health Incorporated (ELAN): Price and Financial Metrics
Elanco Animal Health Incorporated (ELAN)
Today's Latest Price: $22.03 USD
Updated Jul 10 4:32pm
Add ELAN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ELAN Stock Summary
- With a one year PEG ratio of 0.25, Elanco Animal Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 4.93% of US stocks.
- ELAN's went public 1.81 years ago, making it older than only 3.59% of listed US stocks we're tracking.
- Price to trailing twelve month operating cash flow for ELAN is currently 39.44, higher than 90.97% of US stocks with positive operating cash flow.
- Stocks with similar financial metrics, market capitalization, and price volatility to Elanco Animal Health Inc are NTCT, MMSI, QBAK, ENV, and HPE.
- Visit ELAN's SEC page to see the company's official filings. To visit the company's web site, go to www.elanco.com.
ELAN Stock Price Chart Technical Analysis Charts
ELAN Price/Volume Stats
| Current price | $22.03 | 52-week high | $33.94 |
| Prev. close | $21.36 | 52-week low | $15.17 |
| Day low | $21.24 | Volume | 2,443,554 |
| Day high | $22.04 | Avg. volume | 5,410,631 |
| 50-day MA | $21.56 | Dividend yield | N/A |
| 200-day MA | $25.43 | Market Cap | 8.79B |
Elanco Animal Health Incorporated (ELAN) Company Bio
Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. The company is based in Greenfield, Indiana.
ELAN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $22.03 | $0 | -100% |
We started the process of determining a valid price forecast for Elanco Animal Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Elanco Animal Health Inc ranked in the 0th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 100%. As for the metrics that stood out in our discounted cash flow analysis of Elanco Animal Health Inc, consider:
- Its compound free cash flow growth rate, as measured over the past 1.67 years, is -0.78% -- higher than only 0.38% of stocks in our DCF forecasting set.
- As a business, Elanco Animal Health Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -100% |
| 1% | -100% |
| 2% | -100% |
| 3% | -100% |
| 4% | -100% |
| 5% | -100% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ELAN, try ABMC, AGHC, ALC, ANGO, and CSII.
Loading social stream, please wait...